Abstract |
This study has established the presence of IgM against S-nitrosylated proteins in cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients using S-nitrosocysteine epitope (anti-SNOcys) as previously shown in serum. Anti-SNOcys IgM increased significantly in CSF during relapsing-remitting MS compared to milder neurological conditions. Evidence from albumin, IgG and IgM suggest that the production of anti-SNOcys IgM is intrathecal rather than the result of ingress from serum. Two correlations during relapse: between CSF level of anti-SNOcys IgM and time elapsed since relapse onset; and between CSF and serum anti-SNOcys IgM levels, suggest that this antibody may have potential as a biomarker.
|
Authors | Charlotte Hvaring, Snezana Vujicic, Jan O Aasly, Douglas L Feinstein, Linda R White, Anne I Boullerne |
Journal | Journal of neuroimmunology
(J Neuroimmunol)
Vol. 256
Issue 1-2
Pg. 77-83
(Mar 15 2013)
ISSN: 1872-8421 [Electronic] Netherlands |
PMID | 23351705
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 Elsevier B.V. All rights reserved. |
Chemical References |
- Immunoglobulin G
- Immunoglobulin M
- S-Nitrosothiols
- S-nitrosocysteine
- Cysteine
|
Topics |
- Adult
- Cysteine
(analogs & derivatives, immunology)
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Immunoglobulin G
(blood, cerebrospinal fluid)
- Immunoglobulin M
(blood, cerebrospinal fluid)
- Male
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting
(blood, cerebrospinal fluid)
- S-Nitrosothiols
(immunology)
- Statistics as Topic
- Young Adult
|